Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
IART Integra Lifesciences
59.280+0.110+0.19%
Trading Session
02/08 12:40 ET
High
59.640
Open
58.750
Turnover
6.71M
Low
58.190
Pre Close
59.170
Volume
113.31K
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Integra LifeSciences Holdings Co. (NASDAQ:IART) Shares Purchased by Aigen Investment Management LP
Aigen Investment Management LP grew its stake in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Rating) by 238.3% in the third quarter, HoldingsChannel reports. The fund owned 32,664
Estimating The Intrinsic Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)
Does the February share price for Integra LifeSciences Holdings Corporation (NASDAQ:IART) reflect what it's really worth? Today, we will estimate the stock's intrinsic value by taking the expected fu
Integra LifeSciences Enters Into $150M Accelerated Share Repurchase Agreement
BTIG Remains a Hold on Integra Lifesciences (IART)
Campbell Soup Appoints Carrie Anderson Chief Financial Officer
04:41 AM EST, 01/26/2023 (MT Newswires) -- Campbell Soup (CPB) said late Wednesday it has appointed Carrie L. Anderson chief financial officer, effective Feb. 6. Anderson succeeds Mick Beekhuizen, wh
Integra LifeSciences Sees Q4, Full-Year 2022 Adjusted Earnings Above Guidance; CFO Carrie Anderson Resigns
03:35 AM EST, 01/26/2023 (MT Newswires) -- Integra LifeSciences (IART) said Wednesday it expects Q4 adjusted earnings to exceed its guidance range of $0.92 to $0.96 per diluted share. Analysts polled
Campbell Soup Names New CFO as It Looks to Continue Strong Growth -- Update
By Jennifer Williams-Alvarez and Kathryn Hardison Campbell Soup Co. appointed its next finance chief as the soup and snack maker looks to build on its recent growth. The Camden, N.J.-based company o
Piper Sandler Maintains Cautious Stance on Integra LifeSciences
Integra LifeSciences Confirms Carrie Anderson to Step Down as CFO
Integra Lifesciences Sees 4Q Adj EPS 92c-Adj EPS 96c >IART
Integra Lifesciences Sees 4Q Adj EPS 92c-Adj EPS 96c >IART
Company Overview
More
Integra LifeSciences Holdings Corp. engages in the manufacture and sale of medical instruments, devices, and equipment. It operates through the Codman Specialty Surgical and Tissue Technologies segments. The Codman Specialty Surgical segment refers to the company's neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care, such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment, and the precision tools and instruments business, which sells instrument patterns and surgical and lighting products to hospitals, surgery centers, and dental, podiatry, and veterinary offices. The Tissue Technologies segment includes offerings such as skin and wound repair, bone and joint fixation implants in the upper and lower extremities, bone grafts, and nerve and tendon repair. The company was founded by Richard E. Caruso in 1989 and is headquartered in Princeton, NJ.
CEO： Mr. Jan De Witte
Market： NASDAQ
Listing Date： 08/16/1995
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet